As IκB kinases (IKKs), particularly the β-form (i.e., IKK-β), are essential in NF-κB signaling, their inhibition is therefore a promising mechanism for intervention in asthma and COPD. The gene discussed is NFKB1; the disease is chronic obstructive pulmonary disease.